Moreover, several studies have demonstrated that TG2 dysregulation may be involved in many pathological processes and degenerative disorders [5,10,11], including injury associated with ischemic stroke [12], Alzheimer’s disease [13], Parkinson’s disease [14], and Huntington’s disease [15]. Here, TGM2 is linked to early-onset autosomal dominant Alzheimer disease.